Dr Tomasz Bochenek


Medical College of the Jagiellonian University, Krakow, Poland



1. Current Status, Position

Dr Tomasz Bochenek is currently a deputy director of the Institute of Public Health of the Jagiellonian University Medical College in Krakow, and an assistant professor at the Department of Drug Management. He is responsible for teaching and research projects, including the analysis of problems associated with drug shortages in health care systems. Dr Bochenek is an author of about 100 scientific publications and numerous conference presentations, a member of scientific council and an academic editor at scientific journals, and a reviewer of many scientific publications. Dr Bochenek worked in public administration, where his duties were associated with implementing pharmaceutical policy, pricing and reimbursement of medicines and medical devices, as well as utilization of health technology assessment for funding health care services. He was a director of the department responsible for reimbursement of medicines and medical devices at the Sickness Fund and the National Health Fund in Malopolska Province. He also worked as an expert to the Minister of Health, the Agency for Health Technology Assessment and Tariff System, and other institutions.

2. Education

Tomasz Bochenek studied medicine at the Medical College of the Jagiellonian University in Krakow, Poland, and became licensed physician in 1993. He studied also public health and obtained Master of Public Health at the Nordic School of Public Health in Gothenburg, Sweden, in 2006. In 2011 he obtained a PhD in medicine at the Jagiellonian University for his work in area of pharmacoeconomics and health technology assessment.

3. Research Area

Dr Tomasz Bochenek's professional interests and research are focused on pharmaceutical policy, pharmaceutical pricing and reimbursement, management of medicines and medical devices, pharmacoeconomics and health technologies assessment.

Conflict of interest: Dr Tomasz Bochenek received speakers' fee and/or honoraria from Amgen.

Last update: 6 June 2018